We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.5B
AUM Growth
-$348M
Cap. Flow
-$188M
Cap. Flow %
-7.53%
Top 10 Hldgs %
28.24%
Holding
207
New
26
Increased
69
Reduced
85
Closed
27

Top Buys

Rank Stock Value
1
MRX
Marex Group Limited Ordinary Shares
MRX
+$25M
2
ONT
Onterris Inc
ONT
+$21.7M
3
FOUR icon
Shift4
FOUR
+$19.2M
4
PSN icon
Parsons
PSN
+$16.7M
5
ODD icon
ODDITY Tech
ODD
+$14.8M

Top Sells

Rank Stock Value
1
ZETA icon
Zeta Global
ZETA
+$37.1M
2
RGEN icon
Repligen
RGEN
+$22.9M
3
DV icon
DoubleVerify
DV
+$21.6M
4
P
Everpure Inc
P
+$21.1M
5
TOST icon
Toast
TOST
+$19.5M

Sector Composition

Rank Sector Weight
1 Technology 39.53%
2 Healthcare 19.39%
3 Industrials 13.36%
4 Communication Services 7.82%
5 Consumer Discretionary 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCAT icon
101
Health Catalyst
HCAT
$127M
$6.66M 0.27%
1,042,733
-210,971
-17% -$1.35M
KROS icon
102
Keros Therapeutics
KROS
$212M
$6.63M 0.27%
144,976
-4,037
-3% -$217K
KNF icon
103
Knife River
KNF
$3.83B
$6.56M 0.26%
93,508
+19,380
+26% +$1.45M
CIEN icon
104
Ciena
CIEN
$54.9B
$6.54M 0.26%
135,660
+7,667
+6% +$364K
TXG icon
105
10x Genomics
TXG
$7.44B
$6.5M 0.26%
334,007
+155,114
+87% +$4.06M
PRSU
106
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$6.48M 0.26%
190,455
+14,188
+8% +$497K
BBIO icon
107
BridgeBio Pharma
BBIO
$16.6B
$6.37M 0.25%
251,525
-205,461
-45% -$5.62M
DSGX icon
108
Descartes Systems
DSGX
$6.86B
$6.36M 0.25%
65,673
-8,163
-11% -$768K
ITCI
109
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.34M 0.25%
92,585
+42,611
+85% +$2.96M
KNSL icon
110
Kinsale Capital Group
KNSL
$8.4B
$6.3M 0.25%
16,345
-14,935
-48% -$6.06M
ZYME icon
111
Zymeworks
ZYME
$1.71B
$6.28M 0.25%
737,501
+80,894
+12% +$720K
KRUS icon
112
Kura Sushi USA
KRUS
$590M
$6.22M 0.25%
+98,554
New +$9.94M
ALGM icon
113
Allegro MicroSystems
ALGM
$7.91B
$6.2M 0.25%
219,404
+63,424
+41% +$1.81M
EXLS icon
114
EXL Service
EXLS
$5.32B
$6.17M 0.25%
196,656
+11,504
+6% +$345K
ONTO icon
115
Onto Innovation
ONTO
$14.5B
$5.91M 0.24%
26,902
-18,284
-40% -$3.78M
AGIO icon
116
Agios Pharmaceuticals
AGIO
$1.95B
$5.9M 0.24%
+136,838
New +$4.94M
RCUS icon
117
Arcus Biosciences
RCUS
$3.66B
$5.79M 0.23%
379,847
+83,277
+28% +$1.34M
GO icon
118
Grocery Outlet
GO
$972M
$5.69M 0.23%
257,346
+25,432
+11% +$603K
RXST icon
119
RxSight
RXST
$273M
$5.66M 0.23%
94,091
+77,061
+453% +$4.4M
HBIO icon
120
Harvard Bioscience
HBIO
$28.8M
$5.49M 0.22%
192,540
+6,165
+3% +$216K
MEC icon
121
Mayville Engineering Co
MEC
$584M
$5.41M 0.22%
324,434
+133,371
+70% +$2.02M
EXTR icon
122
Extreme Networks
EXTR
$3.09B
$5.29M 0.21%
+393,305
New +$4.52M
NEOG icon
123
Neogen
NEOG
$2.49B
$5.28M 0.21%
338,129
+17,085
+5% +$237K
GH icon
124
Guardant Health
GH
$22.4B
$5.23M 0.21%
181,167
-17,267
-9% -$402K
RMBS icon
125
Rambus
RMBS
$10.4B
$5.08M 0.2%
+86,430
New +$4.94M
3 4
5
6 7

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Granahan Investment Management held 207 positions worth $2.5B, down 12% from $2.85B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Granahan Investment Management withdrew a net $188M in Q2 2024, closing 27 positions and reducing 85 holdings. Its most notable exit was Repligen, an estimated $22.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Marex Group Limited Ordinary Shares worth $25.5M.

  • Granahan Investment Management's largest Q2 2024 buy was Marex Group Limited Ordinary Shares: 1,273,577 shares worth $25.5M.
  • Granahan Investment Management added most to Shift4 in Q2 2024, an estimated $19.2M increase.
  • Granahan Investment Management's biggest Q2 2024 reduction was Zeta Global, cutting an estimated $37.1M.
  • Granahan Investment Management fully exited Repligen in Q2 2024, selling an estimated $22.9M.
  • Granahan Investment Management's ten largest holdings make up 28% of its $2.5B portfolio in Q2 2024.
  • Granahan Investment Management opened 26 new positions and closed 27 in Q2 2024.
  • Granahan Investment Management's portfolio value fell 12% quarter-over-quarter to $2.5B.

Based on Granahan Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.